Tazarotene
Prescription retinoid for the skin, used against acne, psoriasis and sun-related skin aging; not for use in pregnancy.

Related comparisons
Tretinoin vs Tazarotene vs Azelaic acidDETAILED OVERVIEW
What is Tazarotene?
Tazarotene is a prescription medicine applied to the skin and belongs to the retinoids, close relatives of vitamin A. In the United States it is approved for acne, psoriasis and sun-related aging of the facial skin, and it comes in several forms (for example gel, cream and foam). It is also prescription-only in Europe, although availability differs from country to country.
It helps normalize how skin cells mature, reduces excessive cell growth and clogged pores, and also has an anti-inflammatory effect. In studies on acne it worked better than a preparation without the active ingredient, and for sun-related fine wrinkles and blotchy discoloration it worked at least as well as tretinoin. It is stronger and more irritating than tretinoin: the most common side effects are burning or stinging, redness, peeling, dryness and itching, and the skin becomes more sensitive to sunlight. It must not be used in pregnancy, because it can harm the development of the baby; in women who could become pregnant, a negative pregnancy test and reliable contraception are required before treatment.
ATC code
D05AX05 (topical antipsoriatic / retinoid)
Prescription status
Prescription-only (Rx)
Mechanism of action
Selective retinoid; becomes active in the skin, normalizes cell maturation
Strengths
0.045% lotion · 0.05% / 0.1% gel/cream · 0.1% foam
Onset of action
4-8 weeks (acne); 12+ weeks (photoaging, psoriasis)
No anecdote collected yet.
Data console
Lab data
Bershad S, Singer GK, Parente JE, et al. . Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. Arch Dermatol. 2002;138(4):481-489..
Tanghetti EA, Werschler WP, Lain T, et al. . Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials. J Drugs Dermatol. 2020;19(1):70-77..
Kang S, Leyden JJ, Lowe NJ, et al. . Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. Arch Dermatol. 2001;137(12):1597-1604..
Grimes P, Callender V. . Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77(1):45-50..
Safety
Side effects, stop signs, contraindications
Side effects · 4
- Local irritation (the most common): burning/stinging, erythema, peeling, dryness and itching; tazarotene is a more potent and more irritating retinoid than tretinoin, so gradual introduction (alternate days) and a moisturizer are often needed.
- Increased photosensitivity: retinoids thin the stratum corneum, so the skin is more sensitive to sunlight; daily sun protection (SPF 30+) is mandatory and excessive UV exposure and tanning beds must be avoided.
- Initial acne flare ("purging"): in the first weeks acne may transiently worsen as deeper comedones surface; usually settles within a few weeks and is not a treatment failure.
- Contact dermatitis and skin discoloration: rarely allergic or irritant contact dermatitis, plus transient hyper- or hypopigmentation, especially in darker skin types.
Contraindications · 4
- Pregnancy (former FDA X)
- Broken/sunburned skin
- Retinoid-naive/sensitive skin (start with 0.05%)
- Hypersensitivity
Related Hair & Skin
Same therapeutic category
Studies
Related research and clinical findings
Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel
Bershad S, Singer GK, Parente JE, et al.
Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials
Tanghetti EA, Werschler WP, Lain T, et al.
Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks
Kang S, Leyden JJ, Lowe NJ, et al.
Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study
Grimes P, Callender V.
Telegram
Have a question about Tazarotene?
Educational hair and skin info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation. Talk to a dermatologist!
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.